Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Sex hormones and modulators

FDA 2015

Progestogens and estrogens, fixed combinations

Norgestimate and Ethinyl Estradiol

Approved 9 Sept 2015OralTablet

The FDA lists this product in 17 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · TabletANDA205630-001 · Prescription
ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · TabletANDA200538-001 · Prescription
ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA200541-001 · Prescription
ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · TabletANDA201896-001 · Discontinued
ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletThis page
ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · TabletANDA203865-001 · Discontinued
ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · TabletANDA200384-001 · Prescription
ETHINYL ESTRADIOL 0.035MG; NORGESTIMATE 0.25MG · Tablet

More in sex hormones and modulators

Conjugated Estrogensestrogens, conjugated · Tablet
EnzalutamideTablet

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA076627-001 · Discontinued

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA200494-001 · Prescription

ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA203873-001 · Prescription

ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA090479-001 · Discontinued

ETHINYL ESTRADIOL 0.025MG,0.025MG,0.025MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA204057-001 · Prescription

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA205588-001 · Prescription

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA076626-001 · Discontinued

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA201897-001 · Discontinued

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA203870-001 · Discontinued

ETHINYL ESTRADIOL 0.035MG,0.035MG,0.035MG; NORGESTIMATE 0.18MG,0.215MG,0.25MG · TabletANDA200383-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA202132.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Norgestimate and Ethinyl Estradiol
Active substance: ethinyl estradiol
Drug class: Progestogens and estrogens, fixed combinations, Progestogens and estrogens, sequential preparations
Group: Sex hormones and modulators
Route: Oral
Dosage form: Tablet
Applicant: Xiromed
Status: Discontinued
FDA approval: 9 Sept 2015
Application: ANDA202132-001
RxCUI: 4124

Guidelines

Guidelines in obstetrics and gynaecology1,051 guidelines in the library

FDA 2024

Femlyvethinyl estradiol · Tablet, orally disintegrating

FDA 2024EstradiolGel, metered

FDA 2024OspemifeneTablet

FDA 2023Enilloringethinyl estradiol · Ring

FDA 2023Orserduelacestrant hydrochloride · Tablet

FDA 2023Emzahhnorethindrone · Tablet

FDA 2022Haloetteethinyl estradiol · Ring

FDA 2021Veraringethinyl estradiol · Ring

FDA 2021Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarateethinyl estradiol · Capsule

FDA 2021Ethinyl Estradiol and Norelgestrominethinyl estradiol · Film, extended release

FDA 2021Ethinyl Estradiol; Etonogestrelethinyl estradiol · Ring

FDA 2020Dolishaleethinyl estradiol · Tablet

FDA 2020Winleviclascoterone · Cream

FDA 2020Xtandienzalutamide · Tablet

FDA 2020Finzalaethinyl estradiol · Tablet

FDA 2020Twirlaethinyl estradiol · System